MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE

This adverse event was reported 20 times

MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM MONOFLUOROPHOSPHATE AND POTASSIUM NITRATE 1 1.0000
1 SMOFLIPID 1 0.0011
2 COLISTIMETHATE SODIUM 1 0.0006
3 TOBRAMYCIN SOLUTION 4 0.0003
4 TOBRAMYCIN SULFATE 4 0.0003
5 DEXMETHYLPHENIDATE HYDROCHLORIDE 1 0.0002
6 FERRIC CARBOXYMALTOSE 1 0.0002
7 TOBRAMYCIN 4 0.0002
8 ESKETAMINE HYDROCHLORIDE 1 0.0001
9 TRAMETINIB 1 0.0000
See all drugs enriched for association with MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE

MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 Aminoglycoside Antibacterial [EPC] 4 0.0001
2 Provitamin D2 Compound [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
5 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
6 GLP-1 Receptor Agonist [EPC] 1 0.0000
See all drug classes enriched for association with MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE